December 27, 2013

Drug maker Shire is extending the deadline for its offer to buy Exton, Pa.-based ViroPharma for $4.2 billion, Shire said Friday.

November 11, 2013

Shire will pay $4.2 billion to buy a drug maker specializing in treatments for rare diseases.

December 12, 2012

Drug maker ViroPharma has launched an education campaign focused on a rare, debilitating and life-threatening genetic disorder.